plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimolanti, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
plerixafor tillomed
tillomed italia srl - plerixafor - plerixafor
plerixafor aurobindo
eugia pharma (malta) limited - plerixafor - plerixafor
plerixafor seacross
seacross pharma (europe) ltd - plerixafor - plerixafor
plerixafor teva
teva italia s.r.l. - plerixafor - plerixafor
plerixafor viatris
mylan s.p.a. - plerixafor - plerixafor
mozobil
sanofi b.v. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation; lymphoma - immunostimolanti, - mozobil è indicato in combinazione con il fattore distimolazione del granulocyte-per incrementare la mobilizzazione delle cellule staminali ematopoietiche al sangue periferico per la raccolta e il conseguente trapianto autologo in pazienti con linfoma e multiplo cui le cellule scarsamente mobilitare il mieloma.
mozobil 20mg/ml soluzione iniettabile
sanofi-aventis (suisse) sa - plerixaforum - soluzione iniettabile - plerixaforum 20 mg, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - la mobilizzazione di cellule staminali ematopoietiche - synthetika
neofordex
theravia - desametasone - mieloma multiplo - corticosteroidi per uso sistemico - trattamento del mieloma multiplo.
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - altri farmaci sul sistema nervoso - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.